» Articles » PMID: 33804487

Infection in Immunosuppressed Patients: Systematic Review of Cases and Report of the First Oral Manifestation, Focusing on Differential Diagnosis

Overview
Publisher MDPI
Date 2021 Apr 3
PMID 33804487
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Saprochaete clavata infection is an emerging issue in immunosuppressed patients, causing fulminant fungaemia. The purpose of this systematic review of cases is to retrieve all cases of infection and describe oral lesions as the first manifestation of infection. We report the first case of intraoral infection in Acute Myeloid Leukemia (AML) affected subject, presenting as multiple grayish rapidly growing ulcerated swellings, and provide a review of all published cases of infection caused by , according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, conducted by searching SCOPUS, Medline, and CENTRAL databases. Only articles in English were considered. Individual patient data were analyzed to identify risk factors for infection. Seventeen of 68 retrieved articles were included in the review reporting data on 96 patients (mean age 51.8 years, 57 males and 38 females). Most cases were disseminated (86) with a 60.2% mortality rate. Ninety-five were hematological patients, with AML being the most common (57 cases). infection in immunosuppressed patients has a poor prognosis: middle-age patients, male gender and Acute Myeloid Leukemia should be considered risk factors. In immunosuppressed patients, the clinical presentation can be particularly unusual, imposing difficult differential diagnosis, as in the reported case.

Citing Articles

: Emerging Infections from Uncommon Microorganisms in Hematological Diseases.

Duminuco A, Vetro C, Maugeri C, Mauro E, Palumbo G, Parisi M Hematol Rep. 2022; 14(2):67-72.

PMID: 35466175 PMC: 9036236. DOI: 10.3390/hematolrep14020011.


Septic shock due to co-infection with and .

Caldas J, Silva-Pinto A, Faustino A, Figueiredo P, Sarmento A, Santos L IDCases. 2022; 27:e01369.

PMID: 35024339 PMC: 8724953. DOI: 10.1016/j.idcr.2021.e01369.

References
1.
Arendrup M, Boekhout T, Akova M, Meis J, Cornely O, Lortholary O . ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2013; 20 Suppl 3:76-98. DOI: 10.1111/1469-0691.12360. View

2.
Forrestel A, Kovarik C, Katz K . Sexually acquired syphilis: Laboratory diagnosis, management, and prevention. J Am Acad Dermatol. 2019; 82(1):17-28. DOI: 10.1016/j.jaad.2019.02.074. View

3.
DREIZEN S . Oral complications of cancer therapies. Description and incidence of oral complications. NCI Monogr. 1990; (9):11-5. View

4.
Arendrup M, Cuenca-Estrella M, Lass-Florl C, Hope W . EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin Microbiol Infect. 2012; 18(7):E246-7. DOI: 10.1111/j.1469-0691.2012.03880.x. View

5.
Stanzani M, Cricca M, Sassi C, Sutto E, De Cicco G, Bonifazi F . Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature. Mycoses. 2019; 62(12):1100-1107. DOI: 10.1111/myc.12978. View